Noda, Yoshihiro
Barr, Mera S.
Zomorrodi, Reza
Cash, Robin F. H.
Farzan, Faranak
Rajji, Tarek K.
Chen, Robert
Daskalakis, Zafiris J.
Blumberger, Daniel M.
Article History
Received: 18 May 2017
Accepted: 21 November 2017
First Online: 6 December 2017
Competing Interests
: Y.N. receives postdoctoral fellowship from the Centre for Addiction and Mental Health (CAMH) Foundation. M.S.B. receives research support from the Brain and Behavior Research Foundation (Formerly NARSAD) Young Investigator Grant and Schizophrenia Junior Faculty Grant from the CAMH Foundation. R.F.H.C. was supported by a Canadian Institutes of Health Research (CIHR) – Dystonia Medical Research Foundation Fellowship award. F.F. receives funding from NARSAD, Slaight Family Centre for Youth in Transition at the CAMH, Natural Sciences and Engineering Research Council of Canada (NSERC), the Ontario Brain Institute (OBI). T.K.R. received research support from Brain Canada, Brain and Behavior Research Foundation, Canada Foundation for Innovation, the CIHR, Ontario Ministry of Health and Long–Term Care, Ontario Ministry of Research and Innovation, the US National Institute of Health (NIH), and the W. Garfield Weston Foundation. R.C. received research support from the CIHR, the Catherine Manson Chair in Movement Disorders, Medtronic Inc and Merz Pharma. Z.J.D. has received research support from the Ontario Mental Health (OMH) Foundation, the CIHR, the Brain and Behaviour Research Foundation (Formerly NARSAD), and the Temerty family and Grant family through the CAMH Foundation and the Campbell Research Institute. Z.J.D. received research and equipment in kind support for an investigator–initiated study through Brainsway Inc., and a travel allowance through Merck. Z.J.D. has also received speaker funding through Sepracor Inc., and AstraZeneca, served on advisory boards for Hoffmann–La Roche Limited and Merck, and received speaker support from Eli Lilly. D.M.B. has received research support from the CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Research Institute. He receives research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. and he is the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He receives in-kind equipment support from Magventure for an investigator-initiated study. He receives medication supplies for an investigator-initiated trial from Indivior.